Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and Other Funds Acquire Saama Technologies

McGuireWoods LLP

Funds led by Carlyle have acquired a majority stake in Saama Technologies, according to a news release.

The investment is valued at up to $430 million.

Saama, based in Campbell, Calif., is an AI clinical analytics platform company. Founded in 1997, the company states that biotech companies use Saama’s Life Science Analytics Cloud platform to support more than 1,500 studies.

Carlyle, with its U.S. headquarters in Washington, D.C., is a global investment firm that deploys private capital across three business segments: global private equity, global credit and investment solutions. Founded in 1987, the firm targets companies in healthcare and many other industries.

Co-investors joining Carlyle in the investment included Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.